Daré Bioscience, Inc. (DARE) Discusses DARE to PLAY Sildenafil Cream as a Treatment Option for Female Genital Arousal Concerns Transcript
…
0,345$
-6,25%
Echtzeit-Aktienkurs Dare Biosciences Inc.
Bid:
Ask:
Nachrichten zur Dare Biosciences Inc. Aktie
Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates
Dare Bioscience (DARE) delivered earnings and revenue surprises of +15.15% and -95.00%, respectively, for the quarter ended September 2025. Do…
Daré Bioscience, Inc. (DARE) Q1 2025 Earnings Call Transcript
…
Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates
Dare Bioscience (DARE) delivered earnings and revenue surprises of 20.63% and 95.83%, respectively, for the quarter ended March 2025. Do…
Daré Bioscience, Inc. (DARE) Q4 2024 Earnings Call Transcript
…
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates
Dare Bioscience (DARE) delivered earnings and revenue surprises of 3.03% and 101.60%, respectively, for the quarter ended December 2024. Do…
Daré Bioscience, Inc. (DARE) Q3 2024 Earnings Call Transcript
…
Daré Bioscience, Inc. (DARE) Q2 2024 Earnings Call Transcript
…
Daré Bioscience, Inc. (DARE) Q1 2024 Earnings Call Transcript
…
Daré Bioscience, Inc. (DARE) Q4 2023 Earnings Call Transcript
…
Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced…